“Molecular Docking Study For Adenosine Monophosphate-Activated Protein Kinase Agonist From Syzygium Cumini For Treatment Of Diabetes Mellitus-Type 2”, Journal of Pharmaceutical Negative Results, pp. 1078–1085, Jan. 2023, doi: 10.47750/pnr.2023.14.S02.132.